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Abstract 
Background: Staphylococcus aureus (S. aureus), a normal flora of nasal cavity, can cause minor to life threatening 
invasive diseases and nosocomial infections. Methicillin resistant strains of S. aureus are causing a great challenge for 
treatment options. Therefore, the purpose of this study was to assess the nasal carriage rate of S. aureus, its methicillin 
resistant strains and risk factors in medical students prior to clinical exposure.
Methods: The bacterial growth of S. aureus from nasal swab culture was identified by using standard microbiological 
methods recommended by American Society for Microbiology. Modified Kirby–Bauer disk diffusion method was used 
for antibiotic susceptibility testing and methicillin resistance was confirmed using cefoxitin and oxacillin disks. D-zone 
test method was used to determine the inducible clindamycin resistance.
Results: Among 200 participants, nasal carriage of S. aureus was detected from 30 (15 %) subjects. Upper respiratory 
tract infections significantly (P < 0.05) contributed the carriage of S. aureus and their methicillin resistant strains. All of 
the isolates were reported to be susceptible to vancomycin and teicoplanin. S. aureus strains detected from 8 (4 %) 
students were confirmed to be methicillin resistant.
Conclusions: The result of our study demands for strict policy to screen all the students for nasal carriage of S. aureus 
and its MRSA strains to minimize the transmission of this organism from community to hospital settings.
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Background
Staphylococcus aureus (S. aureus) is a normal flora of 
moist squamous epithelium of the anterior nares. Major-
ity of the populations (60  %) are intermittent carriers 
while 20 % of the population is always colonized with S. 
aureus and 20 % of populations never carry this organism 
[1]. The evidence suggests that the populations harboring 
S. aureus and its methicillin resistant (MRSA) strains are 
at higher risk for developing invasive infection [2–4].
A range of minor as well as life threatening condi-
tions like skin infections (pimples, impetigo, boils, cel-
lulitis, folliculitis, carbuncles, scalded skin syndrome, 
abscesses), pneumonia, meningitis, osteomyelitis, endo-
carditis, toxic shock syndrome (TSS), and septicemia can 
be caused by S. aureus [5]. Coagulase negative Staphylo-
coccus species (CoNS) act as the most common causative 
agents of nosocomial bacteremia [6].
Nasal carriage of MRSA contributes as a major risk 
factor for subsequent infection and transmission of this 
pathogen [7, 8]. Prolonged hospitalization, antibiot-
ics exposure, and the presence of other patients with 
MRSA colonization or infection in the hospital are the 
major risk factors for acquiring MRSA infections. MRSA 
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causes life threatening infections and greater mortality 
than that from methicillin-sensitive S. aureus (MSSA) 
infections. Vancomycin, a glycopeptide antibiotic is the 
drug of choice to treat MRSA infections. However, the 
continuous use of vancomycin may promote growth of 
vancomycin-intermediate S. aureus (VISA) and vanco-
mycin-resistant S. aureus (VRSA) [9]. Therefore, this 
study was conducted to assess the nasal carriage rate of S. 
aureus, MRSA, its antimicrobial susceptibility profile and 
the associated risk factors in the medical students prior 
to their clinical exposure.
Methods
This simple and cross-sectional study was carried out at 
Department of Microbiology, Chitwan Medical College 
(having a 600 bed teaching hospital) in the city of Bharat-
pur, Chitwan District, Narayani Zone, Nepal in March, 
2014. A total 200 medical students who were studying in 
their first year of their medical education and were not 
exposed to their clinical posting were enrolled in this 
study.
Data collection
After obtaining the appropriate written consent the par-
ticipants were requested to respond to a questionnaire 
on basic demographic characteristics (gender, residence, 
number of family members, profession of family, fam-
ily income, family education), any potential risk factors 
(history of hypertension, renal disease, lower respira-
tory tract infection (LRTI), gastro-intestinal (GI) disease, 
upper respiratory tract infections (URTIs), recent sur-
gery, recent hospitalization, recent visit to out-patient 
departments (OPD), any recent medication, recent anti-
biotic use, recent visit to hospital admitted family mem-
bers) and habitual factors (vehicle used by participants, 
vehicle used by participants’ family members, recent visit 
to public amusement places, tattoo or acupuncture, alco-
hol consumption habit, contact with livestock and pets) 
during swab collection.
Exclusion criteria
The participants receiving either intranasal antibiotic 
ointment including mupirocin, or antistaphylococcal 
antibiotics including clindamycin, cephalexin, cefazolin, 
oxacillin, dicloxacillin, trimethoprim/sulfamethoxazole, 
linezolid or vancomycin within 2 weeks were excluded in 
this study.
Sample collection
Nasal swabs were collected from both anterior nares of 
the students by using moist cotton swabs. Aseptic tech-
nique (disinfecting outer nostrils with alcohol) was fol-
lowed while collecting the swab samples. The swab 
samples were transported immediately to the laboratory 




For the isolation of S. aureus, the collected swab samples 
were gently rolled and streaked on the 5 % sheep blood 
agar (BA), DNase agar and mannitol salt agar (MSA) 
plates (HiMedia Laboratories Pvt. Limited, India). The 
inoculated BA, DNase and MSA plates were incubated 
at 37  °C for up to 24 h as described in previously pub-
lished article [10]. Identification of S. aureus was carried 
out following standard microbiological methods recom-
mended by American Society for Microbiology (ASM) 
[11].
Antibiotic susceptibility testing
Modified Kirby–Bauer disk diffusion method was used 
for antibiotic susceptibility testing and isolates were con-
sidered either sensitive or resistant in compliance with 
Clinical and Laboratory Standards Institute (CLSI) guide-
lines [12]. Several antibiotics (HiMedia Laboratories, Pvt. 
Limited, India) used were: penicillin G (10 U), ciprofloxa-
cin (5  μg), gentamicin (10  μg), amikacin (30  μg), eryth-
romycin (15  μg), co-trimoxazole (25  μg), tetracycline 
(10 μg), rifampicin (15 μg), vancomycin (30 μg), teicopla-
nin (30 μg), cefoxitin (30 μg), oxacillin (1 μg) and clinda-
mycin (2 μg).
Identification of methicillin resistant strains (MRSA)
Disk approximation method was carried out by using 
oxacillin (1  μg) and cefoxitin (30  μg) disks for identifi-
cation of methicillin resistance in S. aureus. The strains 
showing the diameter of the zone of inhibition (ZOI) 
of ≤10 mm with the oxacillin disk or ≤21 mm with the 
cefoxitin disk were recorded as methicillin resistant as 
recommended by CLSI [13].
Identification of inducible clindamycin resistance in S. 
aureus
Identification of inducible macrolide–lincosamide–strep-
togramin B (iMLSB) resistance in S. aureus was also 
performed by disk approximation method. The method 
involved inoculation of S. aureus isolate on Mueller–
Hinton agar plate and placing clindamycin (CLI) and 
erythromycin (ERY) disks approximately 15  mm apart 
(measured edge to edge); the plate was then incubated 
for 16–18 h. The zone of inhibition around the CLI disk 
proximal to the ERY disk (producing a zone of inhibition 
shaped like the letter D) showing flattening was consid-
ered a positive result and indicates the inducible CLI 
resistance by ERY (a positive “D-zone test”) [13].
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S. aureus ATCC 25923 (for antibiotic sensitivity and 
negative control of methicillin resistance) and ATCC 
43300 (for positive control of methicillin resistance) were 
used as a control organism [10].
Statistical analysis
Statistical analysis was performed using SPSS-16 version. 
Differences in proportions were assessed by Chi square 




The participated population in this study included 200 
(male 105 and female 95) students with male to female 
ratio of 1.1. S. aureus strains were isolated from 30 par-
ticipants giving a prevalence rate of 15 % and out of 30 S. 
aureus strains 8 were identified as MRSA strains giving 
the prevalence rate of 4 %.
Participants with socio‑demographic risk factors
Although the colonization rate in rural residents is higher 
(20.5  %) than urban residents (13.7  %), the association 
was not statistically significant. Non-significantly higher 
colonization rate was also found in participants having 
more than 4 family members (Table 1).
Participants and potential risk factors
Although all of the participants with LRTIs and renal dis-
ease were found colonized with S. aureus due to its small 
sample size (n = 1), the association was not statistically 
significant while 25 % of participants having URTIs were 
significantly colonized with this organism (P  =  0.035) 
(Table 2).
Participants and habitual risk factors
Habitual risk factors like vehicle used by participants and 
their family members, recent visit to public amusement 
places, alcohol consumption, contact with livestock and 
pet did not contribute for the colonization of S. aureus 
(Table 3).
Antimicrobial susceptibility testing profile
Table  4 shows the antimicrobial resistance profile of 30 
S. aureus strains isolated in this study. Among 30 tested 
isolates, resistance to penicillin G was most common 
(73.0 %) and frequent resistance was also noted with cip-
rofloxacin (36.7 %). Eight (26.7 %) isolates were resistant 
to methicillin by cefoxitin and oxacillin disk method and 
4 (13.3  %) isolates were found to have inducible clinda-
mycin resistance by D-zone test. No isolates were found 
resistant to vancomycin and teicoplanin in this study. As 
expected, all of the MRSA strains were resistant to peni-
cillin G (Table 4).
MRSA and associated risk factors
MRSA strains were detected from 8 (4  %) participants. 
Males were more likely to carry MRSA (62.5  %) than 
females but association was not significant (P =  0.295). 
However, URTIs, recent visit to public amusement 
places, contact with pet (dog) and rural type of residence 
were listed as significant contributing risk factors for 
MRSA colonization (Table 5).
Discussions
Now-a-days, the rate of urbanization is increasing in 
search of better life style, jobs, medical facilities and bet-
ter education facilities. The result of our study also indi-
cates that majority of the participants (80.5 %) belonged 
to urban area and 19.5 % of the participants belonged to 
family having health care professions. As pets are being 
taken as close friends to humans, 60 (30 %) participants 
of our study were having pets (mostly dog). Common 
cold, a minor form of URTIs, is common in Nepal and 
thus, 44 (22  %) of the participants were suffering from 
upper respiratory tract infections (URTI) during the 
study period.
Table 1 Participants with  socio-demographic characteris-
tics






 Male 105 (52.5) 14 (13.3) 0.488
 Female 95 (47.5) 16 (16.8)
Residence
 Rural 39 (19.5) 8 (20.5) 0.283
 Urban 161 (80.5) 22 (13.7)
No. of family  
members
 More than 4 106 (53.0) 17 (16.0) 0.660
 Up to 4 94 (47.0) 13 (13.8)
Profession of family
 Health care 39 (19.5) 4 (10.3) 0.458
 Others 161 (80.5) 26 (16.1)
Family income
 Low 15 (7.5) 1 (6.7)
 Middle 154 (77.0) 25 (16.2)
 High 31 (15.5) 4 (12.9)
Family education
 Up to high school 32 (16.0) 7 (21.9) 0.237
 College 168 (84.0) 23 (13.7)
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Although, large proportion of S. aureus carriage is 
through the anterior nares of the nasal passages, it can 
be found on the skin of the host [1]. The combination of 
defective host immunity and the bacterial ability to evade 
host innate immunity results in the ability of the nasal 
passages to harbor S. aureus [14]. Approximately 20 % of 
individuals act as persistent carriers and almost always 
carry one type of strain [15]. In this study, we detected 
15 % nasal carriage of S. aureus in medical students, simi-
lar to the rates detected from Malaysia [16, 17] and Iraq 
[18].
In this study, a non-significant association was 
observed between the S. aureus colonization and type of 
residence. The present analysis found that 73.3 % of the 
students positive for nasal colonization of S. aureus were 
from cities and 83.3 % of participants used public vehicle 
for travelling. The changing pattern of life style in urban 
area like frequent visit of shopping malls and theatres, 
attending parties and travelling via public vehicles bring 
peoples to be in close contact and easily can transmit the 
pathogens to others. Moreover, contaminated door han-
dles of public vehicles also act as source infections.
Although, non-significant association was observed 
between nasal carriage of S. aureus and clinical factors 
such as medication and antibiotic use in last 3  months, 
there was significant association (P = 0.035) with upper 
Table 2 Participants with potential risk factors
Recent—in last 3 months
Variables Total participants (%) Positive participants (%) P values
Hypertension
 Yes 4 (2.0) 1 (25.0) 0.480
 No 196 (98.0) 29 (14.8)
Renal disease
 Yes 1 (0.5) 1 (100.0) 0.15
 No 199 (99.5) 29 (14.6)
LRTI
 Yes 1 (0.5) 1 (100.0) 0.15
 No 199 (99.5) 29 (14.6)
Gastro-intestinal disease
 Yes 17 (8.5) 1 (5.9) 0.477
 No 183 (91.5) 29 (15.8)
URTI
 Yes 44 (22.0) 11 (25.0) 0.035
 No 156 (78.0) 19 (12.2)
Recent surgical procedures
 Yes 2 (1.0) 0 (0)
 No 198 (99.0) 30 (15.2)
Recent admission to hospital
 Yes 8 (4.0) 0 (0)
 No 192 (96.0) 30 (15.6)
Recent visit to out-patient departments
 Yes 50 (25.0) 4 (8.0) 0.168
 No 150 (75.0) 26 (17.3)
Recent medication
 Yes 42 (21.0) 7 (16.7) 0.734
 No 158 (79.0) 23 (14.6)
Recent antibiotic use
 Yes 51 (25.5) 8 (15.7) 0.874
 No 149 (74.5) 22 (14.8)
Recent visit to hospital admitted family members
 Yes 29 (14.5) 6 (20.6) 0.354
 No 171 (85.5) 24 (14.0)
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respiratory tract (nasal) infections in our study. Studies 
from other settings have also reported increased spread 
of S. aureus during an episode of URTIs [19]. In a study 
conducted from Malaysia, 22.5 % cases of nasal carriage 
were associated with URTIs and 9.9 % cases were associ-
ated with recent antibiotic use [17].
The reports of recent study have documented that 
S. aureus can survive on dogs and cats [20, 21]. Some 
authors believe that health-care workers’ dogs should 
be considered a significant source of antibiotic-resistant 
S. aureus, especially during outbreaks [20]. In our study, 
we found that 30 % of the nasal carriers of S. aureus have 
had contact with pet (mostly dog), the findings being 
much lower than the result of 77  % from Virginia [22]. 
The lower rate of our study may be due to the rather still 
uncommon practice of domesticating pets in Nepal than 
others.
Although, the overall resistance rates to commonly 
prescribed antibiotics in isolates were below 50  %, as 
expected the rate was high (73 %) with penicillin because 
only a small proportion of the S. aureus lineages do not 
produce beta-lactamases [23–26]. Similarly, a higher rate 
of resistance (92 %) to ampicillin was also reported in a 
study conducted in Brazil [27].
Ciprofloxacin became the most widely used quinolone 
antibiotic after its introduction into clinical use in the late 
1980s and early 1990s [28, 29]. In recent years, resistance 
has been developed in many bacteria, making it signifi-
cantly less effective [30, 31]. We identified ciprofloxacin 
resistance rate of 36.7 % in this study much higher than 
the result (8.8 %) from Brazil [27]. This high rate of resist-
ance in our study may be because of its indiscriminate 
use in our setting as a consequence of low cost and easy 
availability. Once effective against staphylococcal infec-
tions, the aminoglycoside antibiotics such as kanamycin, 
Table 3 Participants with habitual risk factors
Variables Total participants (%) Positive participants (%) P values
Vehicle used by participants
 Public 168 (84.0) 25 (14.9) 0.920
 Personal 32 (16.0) 5 (15.6)
Vehicle used by participant’s family members
 Public 82 (41.0) 12 (14.6) 0.904
 Personal 118 (59.0) 18 (15.3)
Recent visit to public amusement places
 Yes 106 (53.0) 12 (11.3) 0.122
 No 94 (47.0) 18 (19.1)
Tattoo or acupuncture
 Yes 0 (0) 0 (0)
 No 200 (100) 30 (15.0)
Alcohol consumption habit
 Yes 5 (2.5) 1 (20.0) 0.560
 No 195 (97.5) 29 (14.9)
Contact with livestock
 Yes 26 (13.0) 2 (7.7) 0.263
 No 174 (87.0) 28 (16.0)
Contact with pets
 Yes 60 (30.0) 9 (15.0) 1.0
 No 140 (70.0) 21 (15.0)
Table 4 Antibiotic resistance pattern of S. aureus and MRSA




Penicillin G 22 (73) 8 (100)
Ciprofloxacin 11 (36.7) 6 (75.0)
Gentamicin 10 (33.3) 5 (62.5)
Amikacin 3 (10) 1 (12.5)
Erythromycin 10 (33.3) 5 (62.5)
Cotrimoxazole 6 (20) 4 (50.0)
Tetracycline 6 (20) 3 (37.5)
Rifampicin 6 (20) 3 (37.5)
Vancomycin 0 0
Teicoplanin 0 0
Cefoxitin 8 (26.7) 8 (100)
Oxacillin 8 (26.7) 8 (100)
Clindamycin 8 (26.7) 3 (37.5)
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gentamicin, streptomycin etc., have been found less effec-
tive because of the development of mechanisms to inhibit 
the action, which occurs via protonated amine and/or 
hydroxyl interactions with the ribosomal RNA of the bac-
terial 30S ribosomal subunit [32]. As a consequence of 
low cost and easy availability, there has been indiscrimi-
nate use of this antibiotic similarly as with ciprofloxacin 
in our context. We observed the rate of gentamicin resist-
ance as 33.3 % and amikacin resistance as 10 %. Similar 
rate of gentamicin resistance (25 %) was also detected by 
Sharma et al. [33] whereas lower rate of amikacin resist-
ance (4 %) was also reported from Brazil [27].
Today, the therapeutic roles of erythromycin and tri-
methoprim–sulfamethoxazole (co-trimoxazole) are 
increasingly limited due to its extensive use for the treat-
ment of both minor and serious staphylococcal infec-
tions. One third (33.3  %) of our isolates were resistant 
to erythromycin and 20  % isolates were resistant to 
co-trimoxazole, the results are in agreement with the 
reported finding from Iran [34].
Glycopeptides like vancomycin and teicoplanin could 
be reserved for the management of MRSA infections 
because of its high efficacy in virtually all isolates of S. 
aureus [35, 36]. The result of susceptibility in the cur-
rent study to vancomycin and teicoplanin is comparable 
to that of other studies conducted worldwide [18, 27, 33]. 
The promising efficacy of glycopeptides is probably due 
to high cost and low usage of these regimens in Nepal. 
However, increased resistance to teicoplanin has been 
reported overseas [37–40]. Thus, glycopeptides especially 
vancomycin can be used empirically for serious staphy-
lococcal infections while waiting for susceptibility testing 
results to come through [41].
Methicillin, the first antibiotic of β-lactamase-resistant 
penicillins (methicillin, oxacillin, cloxacillin, and fluclox-
acillin) was detected to be ineffective only after two years 
of its introduction (introduced in 1959) in England and it 
was the first case of MRSA [42]. Then until 1990s, when 
there was an explosion in MRSA prevalence in hospitals, 
MRSA generally remained an uncommon finding, [43]. 
In present study, two different methods, the cefoxitin disk 
and oxacillin disk methods were employed for the detec-
tion of MRSA. According to CLSI guidelines, the mecA 
mediated resistance to oxacillin can be detected by using 
cefoxitin disk or oxacillin disk method but cefoxitin disk 
method is more preferred because it is easier to read and 
also cefoxitin acts as an inducer of the mecA gene [13]. 
Results of the present study indicated that, 4  % (8/200) 
students harbored the MRSA in their nasal cavity. Simi-
larly, 6 % MRSA carriage rate in medical students before 
clinical exposure was also detected from India [44].
Macrolide-resistant isolates of S. aureus may be resist-
ant to only macrolides mediated by efflux mechanism 
encoded by the msrA gene or may have constitutive or 
inducible resistance to clindamycin mediated by meth-
ylation of the 23S rRNA encoded by the erm gene [13]. 
Clindamycin is considered as one of the drugs of choice 
in S. aureus infections but an erm gene mediated induc-
ible resistance may result in treatment failure [45]. In 
our study, we identified 4 isolates (13.3 %) as D-zone test 
positive, indicating inducible resistance to clindamycin. 
Similar result of inducible resistance to clindamycin was 
also reported from Nepal [10].
Spread of S. aureus (including MRSA) is generally 
through human-to-human contact, although recently 
some veterinarians have documented that the infec-
tion can also spread through pets [46]. In a case control 
study, 73  % of MRSA were recovered from pets (cat, 
dog and other rodents) [22]. Similarly, in our study we 
observed that 75  % of MRSA carriers have had contact 
Table 5 Risk factors and MRSA positive cases (N = 8)
Variables Positive numbers (n = 8) P value
Gender
 Male 5 0.295
 Female 3
Co-morbidities
 URTIs 6 0.009
 Others 2
Recent visit to hospital admitted 
family members
 Yes 1 0.536
 No 7
Recent visit to public amusement 
places
 Yes 6 0.018
 No 2
Contact with pet
 Yes (dog) 6 0.0005
 No 2
Type of residence
 Urban 3 0.007
 Rural 5
Vehicle used by participant’s family 
member
 Personal 5 0.866
 Public 3
Profession of family
 Health care 2 0.257
 Other than health care 6
Family income
 Middle 8 0.140
 Others 0
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with pet especially dog. High proportion of MRSA (75 %) 
colonization was also significantly associated with 
URTIs (P = 0.009) and visit to public amusement places 
(P = 0.018). Although the resident type was not associ-
ated with the colonization rate of S. aureus, it did the col-
onization of MRSA in our study (P = 0.007).
Our study had a few limitations, we selected a limited 
pool of antibiotics for susceptibility testing and molecu-
lar studies could not performed to confirm MRSA iso-
lates due to financial constraints.
Conclusions
The result of this study highlights the nasal carriage of 
S. aureus and their methicillin resistant counterparts in 
the medical students. This study indicates that carriage of 
this organism has no significant association with socio-
demographic and habitual risk factors. However, URTIs 
can enhance the carriage of S. aureus as well as their 
MRSA strains. Recent visit to public amusement places, 
contact with dog (pet) and rural residence were also doc-
umented as the significant risk factors contributing the 
MRSA colonization. The colonization of S. aureus and 
MRSA can play a key role in the epidemiology and path-
ogenicity of community as well as hospital associated 
infections. From this study, the longitudinal surveillance 
of nasal carriage of S. aureus should be made an essential 
protocol to minimize the transmission of this organism 
from community to hospital and vice versa.
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